We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
+11.06%
1 Year Est. Return
+16.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$462K
AUM Growth
-$343M
Cap. Flow
-$8.24M
Cap. Flow %
-1,783.16%
Top 10 Hldgs %
53.52%
Holding
157
New
4
Increased
29
Reduced
27
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.99M
2
AVGO icon
Broadcom
AVGO
+$6.76M
3
AMZN icon
Amazon
AMZN
+$3.3M
4
ZBH icon
Zimmer Biomet
ZBH
+$3.25M
5
SYK icon
Stryker
SYK
+$3.13M

Top Sells

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$7.02M
2
PFE icon
Pfizer
PFE
+$6.43M
3
CVS icon
CVS Health
CVS
+$6.39M
4
QCOM icon
Qualcomm
QCOM
+$5.12M
5
SLB icon
SLB Ltd
SLB
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 35.4%
2 Technology 22.91%
3 Financials 9.51%
4 Consumer Discretionary 8.38%
5 Communication Services 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SO icon
126
Southern Company
SO
$109B
$14 ﹤0.01%
200
VB icon
127
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$14 ﹤0.01%
72
-43
-37% -$8.13K
ILMN icon
128
Illumina
ILMN
$31B
$13 ﹤0.01%
72
ADP icon
129
Automatic Data Processing
ADP
$106B
$12 ﹤0.01%
55
KR icon
130
Kroger
KR
$35.4B
$12 ﹤0.01%
275
WOOF icon
131
Petco
WOOF
$797M
$12 ﹤0.01%
1,440
D icon
132
Dominion Energy
D
$60.8B
$10 ﹤0.01%
200
DUK icon
133
Duke Energy
DUK
$97.8B
$10 ﹤0.01%
121
HIG icon
134
Hartford Financial Services
HIG
$38.9B
$10 ﹤0.01%
150
UL icon
135
Unilever
UL
$137B
$10 ﹤0.01%
187
ZBRA icon
136
Zebra Technologies
ZBRA
$14B
$8 ﹤0.01%
2,825
MRK icon
137
Merck
MRK
$322B
-28,482
Closed -$3.03M
NOC icon
138
Northrop Grumman
NOC
$77.1B
-40
Closed -$18K
VGT icon
139
Vanguard Information Technology ETF
VGT
$139B
-1,600
Closed -$77K
VIG icon
140
Vanguard Dividend Appreciation ETF
VIG
$111B
-3,665
Closed -$564K
VTV icon
141
Vanguard Morningstar Value ETF
VTV
$188B
-101
Closed -$14K

Similar funds

Cyrus J. Lawrence's Q2 2023 Portfolio in Review

As of Q2 2023, Cyrus J. Lawrence held 157 positions worth $462K, down 100% from $344M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Cyrus J. Lawrence withdrew a net $8.24M in Q2 2023, closing 9 positions and reducing 27 holdings. Its most notable exit was Merck, an estimated $3.03M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

Against the trend, Cyrus J. Lawrence opened a new position in Broadcom worth $8.22K.

  • Cyrus J. Lawrence's largest Q2 2023 buy was Broadcom: 94,800 shares worth $8.22K.
  • Cyrus J. Lawrence added most to Medtronic in Q2 2023, an estimated $6.99M increase.
  • Cyrus J. Lawrence's biggest Q2 2023 reduction was Jacobs Solutions, cutting an estimated $7.02M.
  • Cyrus J. Lawrence fully exited Merck in Q2 2023, selling an estimated $3.03M.
  • Cyrus J. Lawrence's ten largest holdings make up 54% of its $462K portfolio in Q2 2023.
  • Cyrus J. Lawrence opened 4 new positions and closed 9 in Q2 2023.
  • Cyrus J. Lawrence's portfolio value fell 100% quarter-over-quarter to $462K.

Based on Cyrus J. Lawrence's 13F filing for Q2 2023, filed 11 Aug 2023.